Its transcription complex inhibitor RIN1 inhibited the occurrence and development of HCC by enhancing the activity of infiltrating leukocytes (especially CD8+ T cells) and inhibiting tumor cell proliferation and epithelial-mesenchymal transition. Here, CD8A is linked to hepatocellular carcinoma.